AKT1 and breast cancer: Inhibition of the PI3K–AKT signaling cascade, which is a pathway also controlled by integrins, can activate autophagy and induce quiescence [130], while low or absent AKT signaling in DTC correlates with dormancy in breast cancer patients [130,131].